Imaging in Endocrine Disorders
1st Edition
Published on 18. March 2016
156 pages
978-3-318-02738-9 (ISBN)
Available for download
Description
Revolutionary changes in medical imaging have enormously improved the ability to detect structural and functional organ alterations early. Imaging is becoming an essential tool - in association with hormonal assays - for the diagnosis and management of endocrine disorders. New contrast media and their application to ultrasounds, as well as the opportunity to merge images acquired by functional/metabolic and traditional techniques, allow characterization of key features of identified lesions. Some radiological techniques such as ultrasonography, CT, and MRI are now available in operating rooms, thus supporting a diagnostic and therapeutic approach to endocrine diseases. In this new book, distinguished experts have contributed concise and well-illustrated chapters to describe pathognomonic features of several benign and malignant diseases affecting endocrine glands. They review the main advantages and disadvantages of each diagnostic technique along with indications for selecting a method. As a special feature, online videos of dynamic diagnostic and therapeutic procedures are available. Imaging in Endocrine Disorders is a must read and valuable reference for all professionals dealing with endocrine disorders, including internists and general practitioners who must manage the essential diagnostic workup.
More details
Other editions
Additional editions
M. Buchfelder | F. Guaraldi
Imaging in Endocrine Disorders
Book
03/2016
1st Edition
S. Karger
€179.75
Article exhausted; check different version
Persons
Content
1 - Cover [Seite 1]
2 - Front matter [Seite 4]
3 - Contents [Seite 6]
4 - Preface [Seite 8]
5 - Sonography of Normal and Abnormal Thyroid and Parathyroid Glands [Seite 10]
5.1 - Abstract [Seite 10]
5.2 - Thyroid Ultrasonography [Seite 11]
5.3 - Parathyroid Ultrasonography [Seite 20]
5.4 - References [Seite 23]
6 - Computed Tomography and Magnetic Resonance Imaging of the Thyroid and Parathyroid Glands [Seite 25]
6.1 - Abstract [Seite 25]
6.2 - Thyroid [Seite 25]
6.3 - Parathyroid [Seite 28]
6.4 - References [Seite 31]
7 - Role of Nuclear Medicine in the Diagnosis of Benign Thyroid Diseases [Seite 33]
7.1 - Abstract [Seite 33]
7.2 - Nuclear Medicine: Radiopharmacology and Methods [Seite 34]
7.3 - Devices [Seite 34]
7.4 - Radiopharmaceuticals [Seite 35]
7.5 - Technetium-99m [Seite 35]
7.6 - Measurement of Technetium Uptake [Seite 35]
7.7 - Iodine Isotopes: 123 I and 131 I [Seite 35]
7.8 - Measurement of Iodine Uptake [Seite 36]
7.9 - Thyroid Scintigraphy [Seite 36]
7.10 - Other Thyroid Examinations and Tests [Seite 37]
7.11 - Benign Thyroid Diseases and Indications for Nuclear Medicine Tests [Seite 40]
7.12 - Acknowledgements [Seite 44]
7.13 - References [Seite 44]
8 - Hybrid Molecular Imaging in Differentiated Thyroid Carcinoma [Seite 46]
8.1 - Abstract [Seite 46]
8.2 - The Use of Radioiodine in Thyroid Carcinomas [Seite 47]
8.3 - Single-Photon Emission Computed Tomography/Computed Tomography in Differentiated Thyroid Carcinoma [Seite 49]
8.4 - Position Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma [Seite 51]
8.5 - Conclusions [Seite 52]
8.6 - References [Seite 53]
9 - Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas [Seite 55]
9.1 - Abstract [Seite 55]
9.2 - Technical Details [Seite 56]
9.3 - Resolution [Seite 57]
9.4 - Indications and Typical Findings [Seite 57]
9.5 - Conclusion [Seite 62]
9.6 - References [Seite 62]
10 - Adrenal Imaging: Magnetic Resonance Imagingand Computed Tomography [Seite 64]
10.1 - Abstract [Seite 64]
10.2 - Introduction [Seite 64]
10.3 - Benign Lesions [Seite 70]
10.4 - Malignant Lesions [Seite 73]
10.5 - Image-Guided Intervention [Seite 75]
10.6 - References [Seite 77]
11 - Adrenal Molecular Imaging [Seite 79]
11.1 - Abstract [Seite 79]
11.2 - Molecular Imaging Techniques [Seite 80]
11.3 - Adrenal Incidentalomas [Seite 81]
11.4 - Molecular Imaging of Adrenal Tumors [Seite 82]
11.5 - Primary Aldosteronism [Seite 83]
11.6 - 11 C-Metomidate PET in Adrenocortical Cancer [Seite 83]
11.7 - 123 I-Metomidate SPECT [Seite 84]
11.8 - Pheochromocytoma [Seite 84]
11.9 - References [Seite 87]
12 - Gonadal Imaging in Endocrine Disorders [Seite 89]
12.1 - Abstract [Seite 89]
12.2 - Male Gonads [Seite 89]
12.3 - Female Gonads [Seite 97]
12.4 - References [Seite 104]
13 - Magnetic Resonance Imaging of Pituitary Tumors [Seite 106]
13.1 - Abstract [Seite 106]
13.2 - The Normal Pituitary Gland [Seite 106]
13.3 - Pituitary Adenomas [Seite 108]
13.4 - Collision Lesions of the Pituitary Region [Seite 120]
13.5 - The Postoperative Sella [Seite 120]
13.6 - Differential Diagnosis of Sellar Space-Occupying Lesions [Seite 123]
13.7 - References [Seite 128]
14 - Intraoperative Magnetic Resonance Imaging for Pituitary Adenomas [Seite 130]
14.1 - Abstract [Seite 130]
14.2 - Scanners and Setups [Seite 131]
14.3 - Results of Low-Field Studies [Seite 133]
14.4 - Results of High-Field Studies [Seite 135]
14.5 - Use of Neuronavigation [Seite 136]
14.6 - Intraoperative Imaging and Endoscopic Surgery [Seite 139]
14.7 - Conclusions [Seite 139]
14.8 - References [Seite 139]
15 - Molecular Imaging of Pituitary Pathology [Seite 142]
15.1 - Abstract [Seite 142]
15.2 - Receptor Imaging of Pituitary Tumors [Seite 143]
15.3 - Dopamine D2 Receptor Imaging of Pituitary Adenomas [Seite 143]
15.4 - Dopamine D2 Receptor Imaging of Pituitary Carcinomas [Seite 143]
15.5 - Somatostatin Receptor Scintigraphy of Pituitary Disorders [Seite 144]
15.6 - 18F-Fluorodeoxy-D-Glucose Positron EmissionTomography and Pituitary Pathology [Seite 147]
15.7 - L - 11 C-Methionine Positron Emission Tomography and Pituitary Pathology [Seite 149]
15.8 - Conclusions [Seite 149]
15.9 - References [Seite 149]
16 - Imaging of Neuroendocrine Tumors [Seite 151]
16.1 - Abstract [Seite 151]
16.2 - Imaging Techniques [Seite 152]
16.3 - Neuroendocrine Tumor Characteristics, Presentationand Image Findings [Seite 156]
16.4 - Imaging in Therapy Monitoring [Seite 158]
16.5 - References [Seite 159]
17 - Author Index [Seite 161]
18 - Subject Index [Seite 162]
19 - Cover [Seite 166]
2 - Front matter [Seite 4]
3 - Contents [Seite 6]
4 - Preface [Seite 8]
5 - Sonography of Normal and Abnormal Thyroid and Parathyroid Glands [Seite 10]
5.1 - Abstract [Seite 10]
5.2 - Thyroid Ultrasonography [Seite 11]
5.3 - Parathyroid Ultrasonography [Seite 20]
5.4 - References [Seite 23]
6 - Computed Tomography and Magnetic Resonance Imaging of the Thyroid and Parathyroid Glands [Seite 25]
6.1 - Abstract [Seite 25]
6.2 - Thyroid [Seite 25]
6.3 - Parathyroid [Seite 28]
6.4 - References [Seite 31]
7 - Role of Nuclear Medicine in the Diagnosis of Benign Thyroid Diseases [Seite 33]
7.1 - Abstract [Seite 33]
7.2 - Nuclear Medicine: Radiopharmacology and Methods [Seite 34]
7.3 - Devices [Seite 34]
7.4 - Radiopharmaceuticals [Seite 35]
7.5 - Technetium-99m [Seite 35]
7.6 - Measurement of Technetium Uptake [Seite 35]
7.7 - Iodine Isotopes: 123 I and 131 I [Seite 35]
7.8 - Measurement of Iodine Uptake [Seite 36]
7.9 - Thyroid Scintigraphy [Seite 36]
7.10 - Other Thyroid Examinations and Tests [Seite 37]
7.11 - Benign Thyroid Diseases and Indications for Nuclear Medicine Tests [Seite 40]
7.12 - Acknowledgements [Seite 44]
7.13 - References [Seite 44]
8 - Hybrid Molecular Imaging in Differentiated Thyroid Carcinoma [Seite 46]
8.1 - Abstract [Seite 46]
8.2 - The Use of Radioiodine in Thyroid Carcinomas [Seite 47]
8.3 - Single-Photon Emission Computed Tomography/Computed Tomography in Differentiated Thyroid Carcinoma [Seite 49]
8.4 - Position Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma [Seite 51]
8.5 - Conclusions [Seite 52]
8.6 - References [Seite 53]
9 - Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas [Seite 55]
9.1 - Abstract [Seite 55]
9.2 - Technical Details [Seite 56]
9.3 - Resolution [Seite 57]
9.4 - Indications and Typical Findings [Seite 57]
9.5 - Conclusion [Seite 62]
9.6 - References [Seite 62]
10 - Adrenal Imaging: Magnetic Resonance Imagingand Computed Tomography [Seite 64]
10.1 - Abstract [Seite 64]
10.2 - Introduction [Seite 64]
10.3 - Benign Lesions [Seite 70]
10.4 - Malignant Lesions [Seite 73]
10.5 - Image-Guided Intervention [Seite 75]
10.6 - References [Seite 77]
11 - Adrenal Molecular Imaging [Seite 79]
11.1 - Abstract [Seite 79]
11.2 - Molecular Imaging Techniques [Seite 80]
11.3 - Adrenal Incidentalomas [Seite 81]
11.4 - Molecular Imaging of Adrenal Tumors [Seite 82]
11.5 - Primary Aldosteronism [Seite 83]
11.6 - 11 C-Metomidate PET in Adrenocortical Cancer [Seite 83]
11.7 - 123 I-Metomidate SPECT [Seite 84]
11.8 - Pheochromocytoma [Seite 84]
11.9 - References [Seite 87]
12 - Gonadal Imaging in Endocrine Disorders [Seite 89]
12.1 - Abstract [Seite 89]
12.2 - Male Gonads [Seite 89]
12.3 - Female Gonads [Seite 97]
12.4 - References [Seite 104]
13 - Magnetic Resonance Imaging of Pituitary Tumors [Seite 106]
13.1 - Abstract [Seite 106]
13.2 - The Normal Pituitary Gland [Seite 106]
13.3 - Pituitary Adenomas [Seite 108]
13.4 - Collision Lesions of the Pituitary Region [Seite 120]
13.5 - The Postoperative Sella [Seite 120]
13.6 - Differential Diagnosis of Sellar Space-Occupying Lesions [Seite 123]
13.7 - References [Seite 128]
14 - Intraoperative Magnetic Resonance Imaging for Pituitary Adenomas [Seite 130]
14.1 - Abstract [Seite 130]
14.2 - Scanners and Setups [Seite 131]
14.3 - Results of Low-Field Studies [Seite 133]
14.4 - Results of High-Field Studies [Seite 135]
14.5 - Use of Neuronavigation [Seite 136]
14.6 - Intraoperative Imaging and Endoscopic Surgery [Seite 139]
14.7 - Conclusions [Seite 139]
14.8 - References [Seite 139]
15 - Molecular Imaging of Pituitary Pathology [Seite 142]
15.1 - Abstract [Seite 142]
15.2 - Receptor Imaging of Pituitary Tumors [Seite 143]
15.3 - Dopamine D2 Receptor Imaging of Pituitary Adenomas [Seite 143]
15.4 - Dopamine D2 Receptor Imaging of Pituitary Carcinomas [Seite 143]
15.5 - Somatostatin Receptor Scintigraphy of Pituitary Disorders [Seite 144]
15.6 - 18F-Fluorodeoxy-D-Glucose Positron EmissionTomography and Pituitary Pathology [Seite 147]
15.7 - L - 11 C-Methionine Positron Emission Tomography and Pituitary Pathology [Seite 149]
15.8 - Conclusions [Seite 149]
15.9 - References [Seite 149]
16 - Imaging of Neuroendocrine Tumors [Seite 151]
16.1 - Abstract [Seite 151]
16.2 - Imaging Techniques [Seite 152]
16.3 - Neuroendocrine Tumor Characteristics, Presentationand Image Findings [Seite 156]
16.4 - Imaging in Therapy Monitoring [Seite 158]
16.5 - References [Seite 159]
17 - Author Index [Seite 161]
18 - Subject Index [Seite 162]
19 - Cover [Seite 166]
